A PYMNTS Company

E.U.: Commission approves acquisition of pharma company by rival Watson

By  |  October 5, 2012

The European Commission has cleared under the EU Merger Regulation the proposed acquisition of the Swiss-based pharmaceutical company Actavis by the generic pharmaceutical company Watson of the U.S. After examining the effects of the proposed transaction on the drug market for anti-depressants and anti-hypertensives, the Commission concluded that the transaction would not significantly effect competition in the European Economic Area

Full Content: EU

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.